A critical breakthrough in cancer study is emerging with the use of mini-antibodies to re-engage dysfunctional p53. This essential malignant inhibitor protein is frequently lost in several kinds of cancer, causing https://sound-social.com/story12305198/vhh-fragments-restore-p53-new-promising-hope-for-malignant-therapy